CBPO [China Biologic Products] 10-Q:

[] [CERTIFICATE OF CHANGE OF REGISTERED OFFICE OF CHINA BIOLOGIC PRODUCTS, INC. China Biologic Products, Inc., a corporation organized and existing under the laws of the State of Delaware, hereby certifies as follows: 1. The name of the corporation is China Biologic Products, Inc. 2. The registered o]

CCCR [China Commercial Credit] 10-Q: (Original Filing)

[ITEM 1. FINANCIAL STATEMENTS CHINA COMMERCIAL CREDIT, INC. CONSOLIDATED BALANCE SHEETS June 30, December 31, 2016 2015 (Unaudited) ASSETS Cash $ 1,369,621 $ 306,401 Restricted cash 10,031 388,361 Notes receivable 97,828 15,404 Loans receivable, net of allowance for loan losses $54,488,203 and $55,595,653 for June 30, 2016 and December 31, 2015, respectively 5,666,417 7,481,067 Investment in direct financing lease, net] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Mingjie Zhao, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2016 of China Commercial Credit, Inc.; 2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Long Yi, certify that: 1 I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2016 of China Commercial Credit, Inc.; 2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact] [SECTION 906 OF SARBANES-OXLEY ACT OF 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Mingjie Zhao Chief Executive Officer] [SECTION 906 OF SARBANES-OXLEY ACT OF 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Long Yi Chief Financial Officer (Principal Financial and Accounting Officer)]

By | 2016-08-23T02:00:29+00:00 August 22nd, 2016|Categories: CCCR, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

CCCR [China Commercial Credit] 10-Q: ITEM 1. FINANCIAL STATEMENTS CHINA COMMERCIAL CREDIT, INC.

[ITEM 1. FINANCIAL STATEMENTS CHINA COMMERCIAL CREDIT, INC. CONSOLIDATED BALANCE SHEETS June 30, December 31, 2016 2015 (Unaudited) ASSETS Cash $ 1,369,621 $ 306,401 Restricted cash 10,031 388,361 Notes receivable 97,828 15,404 Loans receivable, net of allowance for loan losses $54,488,203 and $55,595,653 for June 30, 2016 and December 31, 2015, respectively 5,666,417 7,481,067 Investment in direct financing lease, net] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Mingjie Zhao, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2016 of China Commercial Credit, Inc.; 2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Long Yi, certify that: 1 I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2016 of China Commercial Credit, Inc.; 2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact] [SECTION 906 OF SARBANES-OXLEY ACT OF 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Mingjie Zhao Chief Executive Officer] [SECTION 906 OF SARBANES-OXLEY ACT OF 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Long Yi Chief Financial Officer (Principal Financial and Accounting Officer)]

By | 2016-08-23T02:01:23+00:00 August 22nd, 2016|Categories: CCCR, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) ☒ June 30, 2016 For the quarterly period ended: Or ☐ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Ronghua Wang EX-32.1 4 ex32-1.htm EX-32.1] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Qinghua Liu Qinghua Liu Interim Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm EX-32.2]

By | 2016-08-23T01:24:27+00:00 August 22nd, 2016|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 10-Q: FORM 10-Q (Mark One) ☒ June 30, 2016

[FORM 10-Q (Mark One) ☒ June 30, 2016 For the quarterly period ended: Or ☐ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Ronghua Wang EX-32.1 4 ex32-1.htm EX-32.1] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Qinghua Liu Qinghua Liu Interim Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm EX-32.2]

By | 2016-08-23T01:25:20+00:00 August 22nd, 2016|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

CBAK [CHINA BAK BATTERY] 10-Q: (Original Filing)

[FORM 10−Q (Mark One) June 30, 2016 For the quarterly period ended: For the transition period from _____________ to _____________ 001-32898 CHINA BAK BATTERY, INC. Nevada 88-0442833 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) BAK Industrial Park, Meigui Street Huayuankou Economic Zone Dalian City, Liaoning Province, China, 116450 (86)(411)-3918-5985 _____________________________________________________ Large accelerated filer [ ]] [CERTIFICATIONS I, Yunfei Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China BAK Battery, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATIONS I, Wenwu Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China BAK Battery, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. nd Yunfei Li Chief Executive Officer] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. nd Wenwu Wang Interim Chief Financial Officer (Principal Financial and Accounting Officer)]

CBAK [CHINA BAK BATTERY] 10-Q: FORM 10−Q (Mark One) June 30, 2016 For

[FORM 10−Q (Mark One) June 30, 2016 For the quarterly period ended: For the transition period from _____________ to _____________ 001-32898 CHINA BAK BATTERY, INC. Nevada 88-0442833 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) BAK Industrial Park, Meigui Street Huayuankou Economic Zone Dalian City, Liaoning Province, China, 116450 (86)(411)-3918-5985 _____________________________________________________ Large accelerated filer [ ]] [CERTIFICATIONS I, Yunfei Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China BAK Battery, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATIONS I, Wenwu Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China BAK Battery, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. nd Yunfei Li Chief Executive Officer] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. nd Wenwu Wang Interim Chief Financial Officer (Principal Financial and Accounting Officer)]

ALN [American Lorain] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) June 30, 2016 For the quarterly period ended: 001-34449 Commission File No. AMERICAN LORAIN CORPORATION Nevada 87-0430320 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) BeihuanZhong Road Junan County Shandong, People’s Republic of China, 276600 (86) 539-7317959 Large accelerated filer [_] Accelerated filer [_] Non-accelerated filer [_] Smaller reporting company [X] (Do] [CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER I, Si Chen, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q for the period ended June 30, 2016 of American Lorain Corporation. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [CERTIFICATIONS OF CHIEF FINANCIAL OFFICER I, Zhanhai Yang, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q for the period ended June 30, 2016 of American Lorain Corporation 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.]

ALN [American Lorain] 10-Q: FORM 10-Q (Mark One) June 30, 2016 For

[FORM 10-Q (Mark One) June 30, 2016 For the quarterly period ended: 001-34449 Commission File No. AMERICAN LORAIN CORPORATION Nevada 87-0430320 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) BeihuanZhong Road Junan County Shandong, People’s Republic of China, 276600 (86) 539-7317959 Large accelerated filer [_] Accelerated filer [_] Non-accelerated filer [_] Smaller reporting company [X] (Do] [CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER I, Si Chen, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q for the period ended June 30, 2016 of American Lorain Corporation. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [CERTIFICATIONS OF CHIEF FINANCIAL OFFICER I, Zhanhai Yang, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q for the period ended June 30, 2016 of American Lorain Corporation 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.]

EGT [Entertainment Gaming Asia] 10-Q: (Original Filing)

[] [Dated 11 May 2016 ———— Asset purchase agreement (1) Dolphin Products Limited (2) Gaming Partners International Corporation (3) Entertainment Gaming Asia Inc. Contents Clause 1. Interpretation 1 2. Agreement to Sell and Purchase 4 3. Purchase Price 5 4. Payment for Restrictive Covenants 7 5. Earn Out Payments 7 6. Condition and Pre-Closing Covenant 10 7. Closing 11 8. 13] [Section 302 Certification I, Clarence Chung, certify that: 1) I have reviewed this quarterly report on Form 10-Q of Entertainment Gaming Asia Inc.; 2) Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER Section 302 Certification I, Traci L. Mangini, certify that: 1) I have reviewed this quarterly report on Form 10-Q of Entertainment Gaming Asia Inc.; 2) Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the] [1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. Dated: August 15, 2016 Clarence Chung President and Chief Executive Officer Dated: August 15, 2016 Traci L. Mangini Chief Financial Officer This certification is made solely for the purposes of 18 U.S.C. Section 1350, subject to]

By | 2016-08-16T01:41:00+00:00 August 15th, 2016|Categories: Chinese Stocks, EGT, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar